Long‐term cause‐specific mortality in adolescent and young adult Hodgkin lymphoma patients treated with contemporary regimens—A nationwide Danish cohort study
British Journal of Haematology · 2024
DOI: 10.1111/bjh.19586 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift British Journal of Haematology, 2024. Verfasst von Sára Rossetti und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark. Hauptthemen laut MEDLINE: Hodgkin Disease, Antineoplastic Combined Chemotherapy Protocols. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: The Research Fund of Rigshospitalet, Copenhagen University Hospital.
Abstract (Originalsprache)
The documented treatment‐induced excess mortality in Hodgkin lymphoma (HL) has spurred important treatment changes over recent decades. This study aimed to examine mortality among young HL patients treated with contemporary strategies, including historical data comparison. This nationwide study included 1348 HL patients, diagnosed in 1995–2015 and aged 15–40 at diagnosis. Among the patients, 66.5% had Ann Arbor stage I–II and 33.5% had stage III–IV disease. With a median follow‐up of 14.76 years, 139 deaths occurred, yielding a 5‐year overall survival of 94.6%. Older age, advanced disease, earlier treatment periods and extensive regimens were associated with higher overall mortality risk. The cumulative risk of HL‐related death showed an initial sharp rise, with a plateau at 5.3% 10‐year post‐diagnosis. Deaths due to cardiovascular or pulmonary diseases and second cancers initially had minimal risk, gradually reaching 1.2% and 2.0% at the 20‐year mark respectively. HL cases had a 7.5‐fold higher mortality hazard than the background population. This study suggests that contemporary HL treatment still poses excess mortality risk, but recent changes have notably reduced overall and cause‐specific mortality compared to earlier eras. Balancing treatment efficacy and toxicity remains crucial, but our findings highlight improved outcomes with modern treatment approaches.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Hematology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.
- Department of Clinical Oncology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.
- Section of Biostatistics, University of Copenhagen, Copenhagen, Denmark.
- Department of Cardiology, The Heart Centre, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.
- Department of Hematology, Aalborg University Hospital, Aalborg, Denmark.
- Department of Hematology, Odense University Hospital, Odense, Denmark.
ORCID-Profile: Sára Rossetti, Sidsel Jacobsen Juul
Förderung
- The Research Fund of Rigshospitalet, Copenhagen University Hospital
Zitieren
APA
Rossetti, S., Juul, S. J., Eriksson, F., Warming, P. E., Glinge, C., El-Galaly, T. C., Haaber Christensen, J., Kamper, P., de Nully Brown, P., Gislason, G. H., Vestmø Maraldo, M., Tfelt-Hansen, J., & Hutchings, M. (2024). Long‐term cause‐specific mortality in adolescent and young adult Hodgkin lymphoma patients treated with contemporary regimens—A nationwide Danish cohort study. British Journal of Haematology. https://doi.org/10.1111/bjh.19586
Vancouver
Rossetti S, Juul SJ, Eriksson F, Warming PE, Glinge C, El-Galaly TC, et al. Long‐term cause‐specific mortality in adolescent and young adult Hodgkin lymphoma patients treated with contemporary regimens—A nationwide Danish cohort study. British Journal of Haematology. 2024. doi:10.1111/bjh.19586
BibTeX
@article{Rossetti2024,
author = {Rossetti, Sára and Juul, Sidsel Jacobsen and Eriksson, Frank and Warming, Peder Emil and Glinge, Charlotte and El-Galaly, Tarec Christoffer and Haaber Christensen, Jacob and Kamper, Peter and de Nully Brown, Peter and Gislason, Gunnar Hilmar and Vestmø Maraldo, Maja and Tfelt-Hansen, Jacob and Hutchings, Martin},
title = {Long‐term cause‐specific mortality in adolescent and young adult Hodgkin lymphoma patients treated with contemporary regimens—A nationwide Danish cohort study},
journal = {British Journal of Haematology},
year = {2024},
doi = {10.1111/bjh.19586}
}
EUVIMED